CD274 and cancer: We also demonstrate, as a proof of principle, how the model could allow us to predict a scoring system that takes into account not only the relative amount but also the spatial distribution of PDL1+ cancer cells and discerns patients that are likely to respond to anti-PDL1 treatment.